Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. (DCPH) Stock Overview
Explore Deciphera Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.2B
P/E Ratio
-11.17
EPS (TTM)
$-2.21
ROE
-0.56%
DCPH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Deciphera Pharmaceuticals, Inc. (DCPH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $19.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.17 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.